title: Requirement for cyclin D3 in germinal center formation and function.
abstract: Germinal centers (GC) of secondary lymphoid tissues are critical to mounting a high-affinity humoral immune response. B cells within the GC undergo rapid clonal expansion and selection while diversifying their antibody genes. Although it is generally believed that GC B cells employ a unique proliferative program to accommodate these processes, little is known about how the GC-associated cell cycle is orchestrated. The D-type cyclins constitute an important component of the cell cycle engine that enables the cells to respond to physiological changes. Cell type- and developmental stage-specific roles of D-type cyclins have been described but the cyclin D requirement during GC reaction has not been addressed. In this study, we report that cyclin D3 is largely dispensable for proliferation and Ig class switching of in vitro activated B cells. In contrast, GC development in Ccnd3(-/-) mice is markedly impaired, as is the T cell-dependent antibody response. Within the GC, although both switched and unswitched B cells are affected by cyclin D3 inactivation, the IgM(-) pool is more severely reduced. Interestingly, despite a compensatory increase in cyclin D2 expression, a significant number of Ccnd3(-/-) GC B cells accumulate in quiescent G0 state. Lastly, although cyclin D3 inactivation did not disrupt BCL6 expression in GC B cells, it completely blocked the GC promoting effect of BCL6 overexpression, suggesting that cyclin D3 acts downstream of BCL6 to regulate GC formation. This is the first demonstration that cyclin D3 plays an important and unique role at the GC stage of B cell development.
authors.affiliation: Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
authors.forename: Jonathan U
authors.initials: JU
authors.lastname: Peled
authors.forename: J Jessica
authors.initials: JJ
authors.lastname: Yu
authors.forename: Jeganathan
authors.initials: J
authors.lastname: Venkatesh
authors.forename: Enguang
authors.initials: E
authors.lastname: Bi
authors.forename: B Belinda
authors.initials: BB
authors.lastname: Ding
authors.forename: Melissa
authors.initials: M
authors.lastname: Krupski-Downs
authors.forename: Rita
authors.initials: R
authors.lastname: Shaknovich
authors.forename: Piotr
authors.initials: P
authors.lastname: Sicinski
authors.forename: Betty
authors.initials: B
authors.lastname: Diamond
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Scharff
authors.forename: B Hilda
authors.initials: BH
authors.lastname: Ye
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology* / Q000378:metabolism*; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology; D056743:Cyclin D3 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D018858:Germinal Center / Q000166:cytology / Q000276:immunology* / Q000378:metabolism*; D006801:Humans; D008213:Lymphocyte Activation / Q000235:genetics / Q000276:immunology; D008221:Lymphoid Tissue / Q000166:cytology / Q000276:immunology* / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout
chemical_list: D056743:Cyclin D3
references.citation: Cancer Cell. 2005 May;7(5):445-55
references.pmid: 15894265
references.citation: Mol Cell Biol. 2005 Dec;25(23):10205-19
references.pmid: 16287839
references.citation: Immunology. 2004 Aug;112(4):509-20
references.pmid: 15270721
references.citation: J Immunol. 2006 Nov 15;177(10):6930-9
references.pmid: 17082608
references.citation: Nat Immunol. 2004 Feb;5(2):224-9
references.pmid: 14716311
references.citation: Science. 2009 Aug 21;325(5943):1006-10
references.pmid: 19608860
references.citation: Blood. 2005 Feb 15;105(4):1777-84
references.pmid: 15507530
references.citation: Immunity. 2002 Aug;17(2):179-89
references.pmid: 12196289
references.citation: Oncogene. 2009 Aug 20;28(33):2925-39
references.pmid: 19561645
references.citation: J Biol Chem. 2000 Feb 4;275(5):3479-84
references.pmid: 10652342
references.citation: Oncogene. 2008 May 15;27(22):3111-21
references.pmid: 18084330
references.citation: Blood. 2009 May 28;113(22):5536-48
references.pmid: 19307668
references.citation: Nat Immunol. 2004 Mar;5(3):317-27
references.pmid: 14758357
references.citation: Immunity. 2001 Sep;15(3):375-85
references.pmid: 11567628
references.citation: Science. 2009 Aug 21;325(5943):1001-5
references.pmid: 19628815
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3304-9
references.pmid: 16492737
references.citation: J Pathol. 1998 Jun;185(2):159-66
references.pmid: 9713342
references.citation: Nat Immunol. 2009 Oct;10(10):1110-7
references.pmid: 19734904
references.citation: Nat Immunol. 2006 May;7(5):489-97
references.pmid: 16582912
references.citation: Genes Dev. 1999 Jun 15;13(12):1501-12
references.pmid: 10385618
references.citation: Int J Cancer. 1999 May 17;81(4):543-50
references.pmid: 10225442
references.citation: Annu Rev Immunol. 2008;26:481-511
references.pmid: 18304001
references.citation: Blood. 1995 Jul 1;86(1):45-53
references.pmid: 7795255
references.citation: J Clin Invest. 2003 Feb;111(4):529-37
references.pmid: 12588891
references.citation: Cancer Cell. 2003 Dec;4(6):451-61
references.pmid: 14706337
references.citation: Mol Cell Biol. 2008 Apr;28(7):2175-86
references.pmid: 18212045
references.citation: J Exp Med. 1996 May 1;183(5):2303-12
references.pmid: 8642339
references.citation: Immunity. 2000 Aug;13(2):199-212
references.pmid: 10981963
references.citation: Blood. 2001 Nov 1;98(9):2837-44
references.pmid: 11675358
references.citation: Nat Rev Immunol. 2008 Jan;8(1):22-33
references.pmid: 18097447
references.citation: Immunity. 2007 Aug;27(2):190-202
references.pmid: 17723214
references.citation: Immunity. 2009 Sep 18;31(3):457-68
references.pmid: 19631565
references.citation: Cell. 2003 Aug 8;114(3):323-34
references.pmid: 12914697
references.citation: Immunity. 2002 Oct;17(4):501-14
references.pmid: 12387743
references.citation: J Exp Med. 1998 Mar 16;187(6):885-95
references.pmid: 9500791
references.citation: Immunity. 2005 Jun;22(6):749-61
references.pmid: 15963789
references.citation: J Exp Med. 2007 Dec 24;204(13):3095-101
references.pmid: 18039950
references.citation: Science. 1997 Apr 25;276(5312):589-92
references.pmid: 9110977
references.citation: Cell Cycle. 2005 Mar;4(3):388-91
references.pmid: 15738651
references.citation: Cell. 2004 Aug 20;118(4):477-91
references.pmid: 15315760
references.citation: Cell Cycle. 2008 Jul 15;7(14):2215-24
references.pmid: 18635970
references.citation: Annu Rev Immunol. 2008;26:261-92
references.pmid: 18370922
references.citation: J Immunol. 2006 Jul 15;177(2):787-95
references.pmid: 16818732
references.citation: Clin Cancer Res. 2002 Mar;8(3):729-33
references.pmid: 11895902
references.citation: Nature. 2004 Nov 18;432(7015):298-306
references.pmid: 15549091
references.citation: J Immunol. 2006 Oct 1;177(7):4341-9
references.pmid: 16982868
references.citation: J Exp Med. 2009 Aug 31;206(9):2013-25
references.pmid: 19703988
references.citation: Immunity. 2005 Sep;23(3):297-308
references.pmid: 16169502
references.citation: Nat Genet. 1997 Jun;16(2):161-70
references.pmid: 9171827